Search results for "COPD"
New model found to help predict 20-year risk of COPD
Prediction of future lung function could let clinicians identify those at high risk for chronic obstructive pulmonary disease (COPD), but the trajectory of lung function decline varies greatly among individuals, the authors noted.
https://immattersacp.org/weekly/archives/2019/10/01/4.htm
1 Oct 2019
MKSAP Quiz: Posthospital evaluation for severe COPD
A 64-year-old woman is evaluated during a posthospital visit for severe COPD with an FEV1 of 30% of predicted. She has been admitted three times during the last year with acute exacerbations. Following physical and pulmonary exams, what is the most appropriate treatment to reduce this patient's COPD exacerbations?
https://immattersacp.org/weekly/archives/2019/08/20/3.htm
20 Aug 2019
Testing CRP level safely reduced antibiotic use in patients with COPD exacerbation
In patients with chronic obstructive pulmonary disease (COPD) exacerbations, point-of-care testing of C-reactive protein (CRP) level decreased antibiotic use without affecting clinical outcomes, a randomized controlled trial found.
https://immattersacp.org/weekly/archives/2019/07/16/1.htm
16 Jul 2019
MKSAP Quiz: Follow-up of progressive dyspnea
A 42-year-old man is evaluated in the office for follow-up of progressive dyspnea of 2 years' duration. He first noted dyspnea with exercise but now has symptoms when walking up a flight of stairs. Pulmonary function tests 2 years ago showed moderate airflow obstruction. He has no significant smoking history but a family history of emphysema. After physical examination and a chest radiograph, what is the most appropriate test to perform next?
https://immattersacp.org/weekly/archives/2019/06/04/3.htm
4 Jun 2019
Palliative care's place outside cancer
Integrated palliative care is important in offering comfort measures to patients with conditions that are expected to shorten their life spans.
https://immattersacp.org/archives/2019/06/palliative-cares-place-outside-cancer.htm
1 Jun 2019
MKSAP Quiz: 3-year history of dyspnea, cough
A 69-year-old man is evaluated for a three-year history of dyspnea and chronic productive cough. He was diagnosed with chronic obstructive pulmonary disease (COPD) two years ago and has been treated for three exacerbations in the past year. He is taking tiotropium, fluticasone/salmeterol, and albuterol inhalers. Which long-term treatment is most likely to reduce exacerbations?
https://immattersacp.org/weekly/archives/2019/03/05/3.htm
5 Mar 2019
Evidence evolving on aspirin as prevention
Practice-changing points may influence how internists prescribe aspirin for the primary prevention of heart disease.
https://immattersacp.org/archives/2019/03/evidence-evolving-on-aspirin-as-prevention.htm
1 Mar 2019
A defense of proton-pump inhibitors
Data on their risks may seem persuasive, but one expert is not convinced.
https://immattersacp.org/archives/2019/01/a-defense-of-proton-pump-inhibitors.htm
1 Jan 2019
Triple inhaler therapy associated with reduced COPD exacerbations, higher rates of pneumonia
Results of the systematic review and meta-analysis suggest that triple inhaler therapy should be limited to patients with more severe symptoms of chronic obstructive pulmonary disease (COPD) that cannot be adequately managed by dual therapy, the authors said.
https://immattersacp.org/weekly/archives/2018/11/13/2.htm
13 Nov 2018
EpiPen expiration date extended, first generic approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/10/epipen-expiration-date-extended-first-generic-approved.htm
1 Oct 2018